Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.53 USD | -1.60% | -5.47% | -16.47% |
May. 20 | TELA Bio, Inc. Appoints Greg Firestone as Chief Commercial Officer | CI |
May. 10 | Piper Sandler Adjusts Price Target on TELA Bio to $10 From $12, Maintains Overweight Rating | MT |
Financials (USD)
Sales 2024 * | 75.41M | Sales 2025 * | 95.66M | Capitalization | 136M |
---|---|---|---|---|---|
Net income 2024 * | -39M | Net income 2025 * | -34M | EV / Sales 2024 * | 1.81 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.43 x |
P/E ratio 2024 * |
-3.61
x | P/E ratio 2025 * |
-4.42
x | Employees | 227 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 93.41% |
Latest transcript on TELA Bio, Inc.
1 day | -1.60% | ||
1 week | -5.47% | ||
1 month | +22.75% | ||
3 months | -18.20% | ||
6 months | +6.14% | ||
Current year | -16.47% |
Managers | Title | Age | Since |
---|---|---|---|
Antony Koblish
FOU | Founder | 58 | 12-04-16 |
Roberto Cuca
DFI | Director of Finance/CFO | 57 | 21-09-26 |
Marissa Conrad
CTO | Chief Tech/Sci/R&D Officer | - | 21-05-23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lisa Colleran
BRD | Director/Board Member | 66 | 20-04-19 |
Douglas Evans
CHM | Chairman | 59 | 20-04-19 |
Antony Koblish
FOU | Founder | 58 | 12-04-16 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +3.86% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 5.53 | -1.60% | 137,756 |
24-05-30 | 5.62 | -3.60% | 36,792 |
24-05-29 | 5.83 | +1.57% | 69,145 |
24-05-28 | 5.74 | -1.88% | 90,216 |
24-05-24 | 5.85 | -0.68% | 55,242 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.47% | 136M | |
-7.16% | 178B | |
-4.86% | 67.04B | |
-4.28% | 47.24B | |
+10.32% | 44.62B | |
+8.14% | 42.5B | |
+15.76% | 29.99B | |
+15.53% | 25.22B | |
-5.88% | 24.14B | |
-5.38% | 23.69B |
- Stock Market
- Equities
- TELA Stock